FindTrial
Sign In

M703101 phase III study with infantile hemangiomas

M703101 phase III study with infantile hemangiomas

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080222409
Enrollment
Unknown
Registered
2014-03-03
Start date
2014-03-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infantile Hemangiomas

Interventions

investigational material(s) Generic name etc : M703101 INN of investigational material : Therapeutic category code : 327 Agents for pediatric use Dosage and Administration for Investigational materia

Sponsors

Maruho Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 A proliferating infantile hemangioma is present anywhere on the body 2 less than 1 year old

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Success rate of the target infantile hemangioma—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026